APA (7th ed.) Citation

R, R., EY, K., C, M., S, T., AB, S., B, N., & KD, Y. (2026). Validation of the Madrid Genotype Score to Predict Pathogenic Variants in U.S. Dilated Cardiomyopathy Patients. JACC. Advances, 5(4), 102648. https://doi.org/10.1016/j.jacadv.2026.102648

Chicago Style (17th ed.) Citation

R, Resnick, Kao EY, Maynard C, Tabaghi S, Stergachis AB, Nazer B, and Yang KD. "Validation of the Madrid Genotype Score to Predict Pathogenic Variants in U.S. Dilated Cardiomyopathy Patients." JACC. Advances 5, no. 4 (2026): 102648. https://doi.org/10.1016/j.jacadv.2026.102648.

MLA (9th ed.) Citation

R, Resnick, et al. "Validation of the Madrid Genotype Score to Predict Pathogenic Variants in U.S. Dilated Cardiomyopathy Patients." JACC. Advances, vol. 5, no. 4, 2026, p. 102648, https://doi.org/10.1016/j.jacadv.2026.102648.